Butler, Yemima R.
Liu, Yuqing http://orcid.org/0000-0002-7566-8529
Kumbhar, Ramhari
Zhao, Peiran
Gadhave, Kundlik
Wang, Ning
Li, Yanmei
Mao, Xiaobo http://orcid.org/0000-0001-6587-556X
Wang, Wenjing http://orcid.org/0000-0001-6025-9848
Funding for this research was provided by:
U-M | Life Sciences Institute
Article History
Received: 31 May 2021
Accepted: 1 July 2022
First Online: 19 July 2022
Competing interests
: The authors declare the following competing interests: patent application filed by W.W., X.M., Y.B., Y.L., and R.K. with title ‘Compositions and methods for treating alpha-synucleinopathies.’ U.S. Provisional Patent Application No. 63/222,141, filed Jul 15, 2021. Applicants: The Regents of the University of Michigan and The Johns Hopkins University. Patent pending. Some aspects of this paper is included in the patent such as disulfide-bond free PFFNB, AAV delivery of PFFNB2 to treat Parkinson’s Disease. All other authors declare no competing interests.